Cartesian Therapeutics eliminates chief scientific officer position

Cartesian Therapeutics Inc. (NASDAQ: RNAC) eliminated the chief scientific officer position and terminated Christopher Jewell without cause, effective November 14, 2025, according to a company statement.

The company delivered the termination notice to Jewell on October 15, 2025. Jewell entered into a separation agreement with Cartesian Therapeutics on October 20, 2025.

The information was disclosed in a company filing based on the separation agreement between the parties.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Movano (MOVE) Misses Q2 EPS by 195c
• Mosaic sets pricing for tender offers on up to $1.4B in debt